Abstract
Seizures affect between 4 and 6 % of patients within a week of stroke, and between 2.5 and 6.5 % of patients will develop epilepsy post-stroke. Incidence estimates are particularly variable due to differing definitions, study methodologies, populations, and follow-up durations. Stroke types such as subarachnoid haemorrhage (SAH), intracerebral haemorrhage (ICH), and large-volume cortical infarct are likely risk factors.
Investigations should be undertaken to rule out alternative diagnoses such as cardiac disease causing syncope and non-stroke causes of seizures including electrolyte and metabolic abnormalities, malignancy, and drug or alcohol withdrawal. Due to the large number of possible explanations for seizure-like activity, MR imaging is recommended and EEG may be considered to support a probable diagnosis of post-stroke epilepsy. Where the diagnosis remains uncertain, ambulatory monitoring and video telemetry may be helpful.
With the exception of status epilepticus, which requires urgent intervention, antiepileptic drugs should be initiated in a specialist setting after formal diagnosis of epilepsy, taking into account the patient’s age, gender, childbearing potential, comorbidity, and medication history.
A diagnosis of epilepsy has significant psychosocial effects, particularly related to restrictions on driving, which must be addressed appropriately. The DVLA (Driver and Vehicle Licensing Agency) has specific rules where provoked seizures are concerned. Although most patients achieve long-term seizure remission with therapy, epilepsy has been independently associated with greater mortality post-stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jackson JH. Epileptiform convulsions from cerebral disease. In: Taylor J, Holmes G, Walshe FMR, editors. Selected writings of John Hughlings Jackson on epilepsy and epileptiform convulsion. London: Hodder and Stoughton Ltd; 1931. p. 1.
Gowers WR. Epilepsy and other chronic convulsive diseases: their causes, symptoms, and treatment. New York: Win Wood & Co., 1885; London: J and A Churchill, 1901; New York: Dover Publications Inc., 1964.
International League Against Epilepsy. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–85.
Kessler KR, Schnitzler A, Classen J, Benecke R. Reduced inhibition within primary motor cortex in patients with poststroke focal motor seizures. Neurology. 2002;59:1028–33.
Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470–2.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.
Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders? Neurology. 2007;68:326–37.
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia. 2012;34:453–68.
Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet. 2004;363:1184–6.
Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag. 2008;4:715–20.
Beghi E, D’Alessandro R, Beretta S, Consoli D, Crespi V, Delaj L, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011;77:1785–93.
So EL, Annegers JF, Hauser WA, O’Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996;46:350–5.
Aiwansoba IF, Chukwuyem OW. Early post-acute stroke seizures: clinical profile and outcome in a Nigerian stroke unit. Ann Afr Med. 2014;13:11–5.
Huang CW, Saposnik G, Fang J, Steven D, Burneo JG. Influence of seizures on stroke outcomes: a large multicenter study. Neurology. 2014;1–9.
Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ. 1997;315:1582–7.
Graham NSN, Crichton S, Koutroumanidis M, Wolfe CDA, Rudd AG. Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register. Stroke. 2013;44:605–11.
Lossius MI, Rønning OM, Slapø GD, Mowinckel P, Gjerstad L. Poststroke epilepsy: occurrence and predictors-a long-term prospective controlled study (Akershus Stroke Study). Epilepsia. 2005;46:1246–51.
Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Cote R, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617–22.
Misirli H, Ozge A, Somay G, Erdoğan N, Erkal H, Erenoğlu NY. Seizure development after stroke. Int J Clin Pract. 2006;60:1536–41.
Gupta SR, Naheedy MH, Elias D, Rubino FA. Postinfarction seizures. A clinical study. Stroke. 1988;19:1477–81.
Olafsson E, Gudmundsson G, Hauser WA. Risk of epilepsy in long-term survivors of surgery for aneurysmal subarachnoid hemorrhage: a population-based study in Iceland. Epilepsia. 2000;41:1201–5.
Ferro JM, Canhão P, Bousser M-G, Stam J, Barinagarrementeria F. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39:1152–8.
Benbir G, Ince B, Bozluolcay M. The epidemiology of post-stroke epilepsy according to stroke subtypes. Acta Neurol Scand. 2006;114:8–12.
Preter M, Tzourio C, Ameri A, Bousser M-G. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke. 1996;27:243–6.
Heuts-van Raak L, Lodder J, Kessels F. Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure. 1996;5:185–94.
Szaflarski JP, Rackley AY, Kleindorfer DO, Khoury J, Woo D, Miller R, et al. Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia. 2008;49:974–81.
Kammersgaard LP, Olsen TS. Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis. 2005;14:210–4.
Strzelczyk A, Haag A, Raupach H, Herrendorf G, Hamer HM, Rosenow F. Prospective evaluation of a post-stroke epilepsy risk scale. J Neurol. 2010;257:1322–6.
Rolak LA, Rutecki P, Ashizawa T, Harati Y. Clinical features of Todd’s post-epileptic paralysis. J Neurol Neurosurg Psychiatry. 1992;55(1):63–4.
Summary of product characteristics alteplase. Electronic medicines compendium. 2013. Available at: http://www.medicines.org.uk/emc/medicine/308/SPC/Actilyse.
Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
Selim M, Kumar S, Fink J, Schlaug G, Caplan LR, Linfante I. Seizure at stroke onset: should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis. 2002;14:54–7.
Sylaja PN, Dzialowski I, Krol A, Roy J, Federico P, Demchuk AM. Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset. Stroke. 2006;37:915–7.
Rodan LH, Aviv RI, Sahlas DJ, Murray BJ, Gladstone JP, Gladstone DJ. Seizures during stroke thrombolysis heralding dramatic neurologic recovery. Neurology. 2006;67(11):2048–9.
Shorvon S, Guerrini R, Cook M, Lhatoo SD, editors. Oxford textbook of epilepsy and epileptic seizures. Oxford: Oxford University Press; 2013.
Alarcon G, Valentin A, editors. Introduction to epilepsy. Cambridge: Cambridge University Press; 2012.
Shorvon SD, Baulac TM, Cross H, Trinka E, Walker M, Task Force on Status Epilepticus of the ILAE. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London colloquium on status epilepticus. Epilepsia. 2008;49:2177–84. 107.
National Institute for Health and Care Excellence. Clinical Guideline 137. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. HMSO. 2012.
Chen DK, So YT, Fisher RS. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65(5):668–75.
Mecarelli O, Pro S, Randi F, Dispenza S, Correnti A, Pulitano P, et al. EEG patterns and epileptic seizures in acute phase stroke. Cerebrovasc Dis. 2011;31(2):191–8.
Olsen TS, Langhorne P, Diener HC, Hennerici M, Ferro J, Sivenius J, et al. European stroke initiative recommendations for stroke management-update 2003. Cerebrovasc Dis. 2003;16:311–37.
Sykes L, Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev. 2014;1:CD005398.
Gilad R, Boaz M, Dabby R, Sadeh M, Lampl Y. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment? Epilepsy Res. 2011;95:227–31.
Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Out. Stroke. 2007;38:2001–23.
Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43(10):1175–80.
Joint Formulary Committee. British national formulary. 67th ed. London: BMJ Group and Pharmaceutical Press; 2014.
Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014;348:g254.
Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005;64:1868–73.
Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, Lampl Y. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clin Neuropharmacol. 2007;30:189–95.
Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 1999;37:81–7.
Saetre E, Perucca E, Isojärvi J, Gjerstad L. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia. 2007;48:1292–302.
Pack A. Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure. 2008;17:181–6.
Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, et al. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women’s health initiative (WHI). J Bone Miner Res. 2010;25:873–81.
Goldstein L. Common drugs may influence motor recovery after stroke. Neurology. 1995;45:865–87.
Mula M, Trimble MR, Thompson P, Sander JWAS. Topiramate and word-finding difficulties in patients with epilepsy. Neurology. 2003;60:1104–7.
Stephen LJ, Maxwell JE, Brodie MJ. Transient hemiparesis with topiramate. BMJ. 1999;318:845.
Hesdorffer DC, Berg AT, Kanner AM. An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr. 2010;10:137–45.
Cervoni L, Artico M, Salvati M, Bristot R, Franco C, Delfini R. Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev. 1994;17(3):185–8.
Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60.
Cockerell OC, Johnson AL, Sander JW, Shorvon SD. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia. 1997;38:31–46.
Shafer SQ, Hauser WA, Annegers JF, Klass DW. EEG and other early predictors of epilepsy remission: a community study. Epilepsia. 1988;29:590–600.
Placencia M, Sander JW, Roman M, Madera A, Crespo F, Cascante S, et al. The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry. 1994;57:320–5.
Nicoletti A, Sofia V, Vitale G, Bonelli SI, Bejarano V, Bartalesi F, et al. Natural history and mortality of chronic epilepsy in an untreated population of rural Bolivia: a follow-up after 10 years. Epilepsia. 2009;50:2199–206.
Argyriou AA, Papapetropoulos S, Polychronopoulos P, Corcondilas M, Argyriou K, Heras P. Psychosocial effects and evaluation of the health-related quality of life in patients suffering from well-controlled epilepsy. J Neurol. 2004;251:310–3.
Drivers Medical Group, DVLA. At a glance guide to the current medical standards of fitness to drive. HSMO. 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Graham, N.S.N., Holmes, P.A., Rudd, A.G. (2015). Post-stroke Seizures. In: Bhalla, A., Birns, J. (eds) Management of Post-Stroke Complications. Springer, Cham. https://doi.org/10.1007/978-3-319-17855-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-17855-4_4
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17854-7
Online ISBN: 978-3-319-17855-4
eBook Packages: MedicineMedicine (R0)